pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
bivalirudin
Bivalirudin (bivalirudin)
Heparin-Induced Thrombocytopenia
Avenacy Inc
0 catalysts
Phase 2
bivamelagon
bivamelagon [INN]
Obesity
$RYTMRHYTHM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
bizaxofusp
bizaxofusp [INN]
Recurrent Glioblastoma Multiforme (GBM)
$MDNAFMedicenna Therapeutics Corp.
0 catalysts
← prev
page 190 of 271
next →
131
Pain89
Neurology1
Marketed
black widow spider [Latrodectus mactans] antivenom [equine]
Antivenin (Lacrodectus mactans)
Poisoning
$MRKMerck & Co., Inc.
0 catalysts
Phase 3
blarcamesine hydrochloride
Fragile X Syndrome
$AVXLANAVEX LIFE SCIENCES CORP.
0 catalysts
Marketed
bleomycin sulfate
Bleomycin Sulfate (bleomycin sulfate)
Cervical Cancer
Northstar Rx LLC
0 catalysts
Phase 2
bleximenib besylate
Refractory Acute Myeloid Leukemia
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
bocunebart
bocunebart [INN]
Migraine
H. Lundbeck AS
0 catalysts
Phase 3
bomedemstat tosylate
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
bosakitug
bosakitug [INN]
Atopic Dermatitis (Atopic Eczema)
$ACRSAclaris Therapeutics, Inc.
0 catalysts
Marketed
bosentan ODT
Tracleer (bosentan)
Pulmonary Arterial Hypertension
Janssen-Cilag Holdings Inc (Inactive)
0 catalysts
Marketed
bosutinib
Bosutinib (bosutinib)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Alembic Pharmaceuticals Inc
0 catalysts
Phase 3
botaretigene sparoparvovec
Retinitis Pigmentosa (Retinitis)
Johnson & Johnson Innovative Medicine
0 catalysts
Phase 2
botensilimab
Metastatic Colorectal Cancer
$AGENAGENUS INC
0 catalysts
Phase 2
botulinum vaccine [serogroups A, A1, B and B1]
Botulism
U.S. Army Medical Research Institute of Infectious Diseases
0 catalysts
Marketed
botulism [Clostridium botulinum] [serotype A, B, C, D, E, F, G] (heptavalent) antitoxin [equine]
BAT
Botulism
$EBSEmergent BioSolutions Inc.
0 catalysts
Marketed
botulism immune globulin (human)
Babybig (botulism immune globulin (human))
Botulism
FFF Enterprises Inc
0 catalysts
Phase 3
brelovitug
brelovitug [INN]
Hepatitis D
$MIRMMirum Pharmaceuticals, Inc.
0 catalysts
Marketed
bremelanotide acetate
Vyleesi (bremelanotide acetate)
Obesity
Melanocortin receptor 4
$PTNTPALATIN TECHNOLOGIES INC
0 catalysts
Marketed
brensocatib
Brinsupri (brensocatib)
Bronchiectasis
$INSMINSMED Inc
0 catalysts
Marketed
brexanolone
Brlizio (brexanolone)
Post Partum Depression (Maternal Depression / Postnatal Depression)
GABA-A receptor; anion channel
$LPCNLipocine Inc.
0 catalysts
Phase 1
brexpiprazole LAI
brexpiprazole
Schizophrenia
5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 1A
Bostal Drug Delivery Co Ltd
0 catalysts
Phase 2
brexucabtagene autoleucel
Tecartus (brexucabtagene autoleucel)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
B-lymphocyte antigen CD19
$GILDGILEAD SCIENCES, INC.
0 catalysts
Marketed
brigatinib
Alunbrig (brigatinib)
Non-Small Cell Lung Cancer
Takeda Pharmaceuticals USA Inc
0 catalysts
Phase 2
brilacidin
Chemotherapy Induced Oral Mucositis
Innovation Pharmaceuticals Inc
0 catalysts
Phase 3
brilaroxazine hydrochloride
Schizophrenia
$RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC.
0 catalysts
Preclinical
brimonidine
BRIMONIDINE (brimonidine)
Glaucoma
TearClear Corp
0 catalysts
Marketed
brinzolamide
Brinzolamide (brinzolamide)
Ocular Hypertension
Bausch Health US LLC
0 catalysts
Phase 2
briquilimab
Chronic Urticaria
Mast/stem cell growth factor receptor Kit
$JSPRJasper Therapeutics, Inc.
0 catalysts
Marketed
brodalumab
Siliq (brodalumab)
Plaque Psoriasis (Psoriasis Vulgaris)
Bausch Health US LLC
0 catalysts